Human Centriole and Centrosome Antibody IgG ELISA Kit |
MBS039049-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the protacs medchemexpress reagents distributed by Genprice. The Protacs Medchemexpress reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact MedChemExpress Inc.. Other Protacs products are available in stock. Specificity: Protacs Category: Medchemexpress
Human True insulin ELISA kit |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human True Insulin ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human True Insulin ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human True Insulin ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Chemicals information
PROTAC PTK6 ligand-1 |
HY-139660 |
MedChemExpress |
1 mg |
EUR 6958.98 |
Description: PROTAC PTK6 ligand-1 is an intermediate for BTK kinase inhibitor preparation[1]. PROTAC PTK6 ligand-1 can be used in the synthesis of ARD-61 (HY-139659)[2]. |
PROTAC EGFR degrader 8 |
HY-153901 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC EGFR degrader 8 (T-184) is a PROTAC EGFR degrader. PROTAC EGFR degrader 8 degrades EGFR in HCC827 cell with a DC50 of 15.56 nM. PROTAC EGFR degrader 8 inhibits H1975, PC-9, HCC827 cell growth with IC50s of 7.72 nM, 121.9 nM, 14.21 nM. PROTAC EGFR degrader 8 can be used for research of cancer, especially NSCLC[1]. |
PROTAC HK2 Degrader-1 |
HY-155008 |
MedChemExpress |
1 mg |
EUR 1689.42 |
Description: PROTAC HK2 Degrader-1 is a PROTAC consisting of Lonidamine (HY-B0486) as a target protein Hexokinase 2 (HK2) inhibitor and Thalidomide (HY-14658) as a CRBN ligand-linked PROTAC. PROTAC HK2 Degrader-1 selectively inhibits the proliferation of breast cancer cells by forming a ternary complex through the ubiquitin-proteasome system to degrade Hexokinase 2 (HK2) protein leading to mitochondrial damage and cell death. PROTAC HK2 Degrader-1 effectively inhibits breast tumor growth and reduces the colonic side effects of cisplatin for breast cancer research[1]. |
PROTAC BTK Degrader-5 |
HY-155072 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC BTK degraders-5(compound 3e) is a selective BTK degrader with a DC50 value of 7.0 nM in JeKo-1 cells. PROTAC BTK degraders-5 has no off-target effect on degrading CRBN neosubstates. PROTAC BTK degraders-5 has anti-proliferation effect on various lymphoma tumor cells and can be used in chronic lymphoid malignancies research1. |
PROTAC TG2 degrader-2 |
HY-155102 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC TG2 degrader-2 (compound 7) is a selective, competitive degrader targeting Transglutaminase 2 (TG2), with Kd > 100 μM. PROTAC TG2 degrader-2 inhibits the cell migration and decreases the level of TG2 in ovarian cancer cells. PROTAC TG2 degrader-2 can be used for ovarian cancer study[1]. |
PROTAC TG2 degrader-1 |
HY-155643 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC TG2 degrader-1 (compound 11) is a von Hippel-Lindau (VHL)-based PROTAC targeting tissue transglutaminase (TG2) with a KD of 68.9 μM. PROTAC TG2 degrader-1 reduces TG2 in ovarian cancer cells in a proteasome-dependent manner[1]. |
PROTAC IRAK4 ligand-3 |
HY-145484 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC IRAK4 ligand-3 is a ligand of PROTAC IRAK4 degrader-7 (HY-145483). PROTAC IRAK4 ligand-3 can be used for the research of cancer[1]. |
PROTAC EGFR degrader 4 |
HY-146349 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC EGFR degrader 4 is a potent PROTAC targeting mutant EGFR.PROTAC EGFR degrader 4 induces EGFRdel19 and EGFRL858R/T790M degradation with DC50s of 0.51 and 126 nM, respectively. PROTAC EGFR degrader 4 significantly inhibits growth of HCC827 and H1975 cell lines with IC50s of 0.83 and 203.1 nM, respectively. Induced EGFR degradation is related to autophagy[1]. |
PROTAC EGFR degrader 5 |
HY-146422 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC EGFR degrader 5 (Compound 10), a PROTAC EGFR degrader, potently degrades EGFRDel19 in HCC827 cells with the DC50 of 34.8 nM. PROTAC EGFR degrader 5 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase[1]. |
PROTAC EGFR degrader 6 |
HY-146423 |
MedChemExpress |
Get quote |
Ask for price |
Description: PROTAC EGFR degrader 6, a PROTAC EGFR degrader, potently degrades EGFRDel19 in HCC827 cells with the DC50 of 45.2 nM. PROTAC EGFR degrader 6 significantly induces the apoptosis of HCC827 cells and arrest the cells in G1 phase[1]. |